Skip to main content

3 Reasons Investors Love Alignment Healthcare (ALHC)

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

ALHC Cover Image

Alignment Healthcare’s 21.4% return over the past six months has outpaced the S&P 500 by 16.6%, and its stock price has climbed to $21.00 per share. This performance may have investors wondering how to approach the situation.

Is it too late to buy ALHC? Find out in our full research report, it’s free.

Why Is Alignment Healthcare a Good Business?

Founded in 2013 with a mission to transform healthcare for seniors, Alignment Healthcare (NASDAQ: ALHC) provides Medicare Advantage health plans for seniors with features like concierge services, transportation benefits, and technology-driven care coordination.

1. Skyrocketing Revenue Shows Strong Momentum

A company’s long-term performance is an indicator of its overall quality. Any business can put up a good quarter or two, but the best consistently grow over the long haul. Thankfully, Alignment Healthcare’s 32.7% annualized revenue growth over the last five years was incredible. Its growth surpassed the average healthcare company and shows its offerings resonate with customers.

Alignment Healthcare Quarterly Revenue

2. Outstanding Long-Term EPS Growth

We track the long-term change in earnings per share (EPS) because it highlights whether a company’s growth is profitable.

Alignment Healthcare’s full-year EPS flipped from negative to positive over the last four years. This is a good sign and shows it’s at an inflection point.

Alignment Healthcare Trailing 12-Month EPS (Non-GAAP)

3. Increasing Free Cash Flow Margin Juices Financials

Free cash flow isn't a prominently featured metric in company financials and earnings releases, but we think it's telling because it accounts for all operating and capital expenses, making it tough to manipulate. Cash is king.

As you can see below, Alignment Healthcare’s margin expanded by 11.2 percentage points over the last five years. Alignment Healthcare’s free cash flow margin for the trailing 12 months was 2.9%.

Alignment Healthcare Trailing 12-Month Free Cash Flow Margin

Final Judgment

These are just a few reasons why we think Alignment Healthcare is a great business, and with its shares topping the market in recent months, the stock trades at 47.1× forward P/E (or $21.00 per share). Is now the right time to buy? See for yourself in our comprehensive research report, it’s free.

High-Quality Stocks for All Market Conditions

ONE MORE THING: Top 6 Stocks for This Week. This market is separating quality stocks from expensive ones fast. AI taking down whole sectors with no warning. In a rotation this fast, you need more than a list of good companies.

Our AI system flagged Palantir before it ran 1,662%. AppLovin before it ran 753%. Nvidia before it ran 1,178%. Each week it produces 6 new names that pass the same tests. Get Our Top 6 Stocks for Free HERE.

Stocks that have made our list include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today.

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  255.36
+0.00 (0.00%)
AAPL  273.17
+0.00 (0.00%)
AMD  303.46
+0.00 (0.00%)
BAC  53.12
+0.00 (0.00%)
GOOG  337.73
+0.00 (0.00%)
META  674.72
+0.00 (0.00%)
MSFT  432.92
+0.00 (0.00%)
NVDA  202.50
+0.00 (0.00%)
ORCL  187.50
+0.00 (0.00%)
TSLA  387.51
+0.00 (0.00%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.